ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,050.61
-0.39%
Dow Jones
43,449.90
-0.61%
US Dollar vs MXN
20.1675
-0.05%
Brent Oil
73.175
0.10%
Bitcoin
105,281.68
-0.82%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC

  6. Cell MedX Corporation (PK) (CMXC) Cotización

Cell MedX Corporation (PK)

Cell MedX Corporation (PK) (CMXC)

Ishr Mexico Cap
0.0288
0.00
(0.00%)
Cerrado 17 Diciembre 3:00PM
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
0.0288
Postura de Compra
0.0013
Postura de Venta
0.0295
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.093 Rango de 52 semanas 3.42
Capitalización de Mercado [m]
1.271M
Precio Anterior
0.0288
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
8,052
Acciones en circulación
44,138,372
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-9.38
Beneficio por acción (BPA)
-0
turnover
-
Beneficio neto
-142k

Acerca de Cell MedX Corporation (PK)

Cell MedX Corp. is a biotech company focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness and alleviate complications associated with medical conditions including, but not limited to:diabetes, Parkinson's disease, high ... Cell MedX Corp. is a biotech company focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness and alleviate complications associated with medical conditions including, but not limited to:diabetes, Parkinson's disease, high blood pressure, neuropathy and kidney function. Mostrar más

Sector
Surgical,med Instr,apparatus
Industria
Surgical,med Instr,apparatus
Sede
Carson City, Nevada, USA
Fundado
-
Cell MedX Corporation (PK) is listed in the Surgical,med Instr,apparatus sector of the OTCMarkets with ticker CMXC. The last closing price for Cell MedX (PK) was US$0.03. Over the last year, Cell MedX (PK) shares have traded in a share price range of US$ 0.093 to US$ 3.42.

Cell MedX (PK) currently has 44,138,372 shares in issue. The market capitalisation of Cell MedX (PK) is US$1.27 million. Cell MedX (PK) has a price to earnings ratio (PE ratio) of -9.38.

CMXC Últimas noticias

Más noticias

Form 8-K - Current report

05 Noviembre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

15 Octubre 2024
Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

29 Agosto 2024
Edgar (US Regulatory)

Form DEF 14C - Other definitive information statements

06 Marzo 2024
Edgar (US Regulatory)

Form PRE 14C - Other preliminary information statements

22 Febrero 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

22 Febrero 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

16 Enero 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

09 Enero 2024
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

09 Enero 2024
Edgar (US Regulatory)

Form 8-K - Current report

19 Diciembre 2023
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
12-0.3777-92.91512915130.40650.450.184580520.32453094CS
26-0.4692-94.21686746990.4980.6450.093185450.38986988CS
52-0.0762-72.57142857140.1053.420.093287230.45952626CS
156-2.5815-98.89667854272.610313.9681.5E-5260700.71797708CS
260-4.3212-99.33793103454.3513.9681.5E-5429794.06772448CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
IBKKFImining Technologies Inc (CE)
US$ 0.05
(4,999,900.00%)
833
WRCDFWirecard AG (CE)
US$ 0.01
(999,900.00%)
250
SLAAFSitios Latinoamerica SAB de CV (PK)
US$ 0.189
(94,400.00%)
21.85k
MIKPMike The Pike Productions Inc (CE)
US$ 0.0002
(19,900.00%)
520k
KBNTKubient Inc (CE)
US$ 0.0002
(19,900.00%)
1.48k
AMHGQAmergent Hospitality Group Inc (CE)
US$ 0.000001
(-100.00%)
76.67k
CLVRClever Leaves Holdings Inc (CE)
US$ 0.000001
(-100.00%)
240
NEPTFNeptune Wellness Solutions Inc (CE)
US$ 0.000001
(-100.00%)
3.72k
ORMTQOrmet Corp (CE)
US$ 0.000001
(-99.99%)
500k
RKIGFReko International Group Inc (PK)
US$ 0.0006
(-99.98%)
100
RDARRaadr Inc (PK)
US$ 0.001
(-28.57%)
320.76M
HMBLHUMBL Inc (PK)
US$ 0.0012
(-4.00%)
311.02M
MMEXMMEX Resources Corporation (PK)
US$ 0.0001
(9,900.00%)
265.88M
EARIEntertainment Arts Research Inc (PK)
US$ 0.0001
(0.00%)
213.32M
CGACCode Green Apparel Corp (PK)
US$ 0.0005
(-16.67%)
125.52M

Discusión

Ver feed completo
TheDane TheDane 5 minutos hace
Not only did it hold but it’s on the way back up.
SMCI
OnTrack444 OnTrack444 5 minutos hace
Might see a dime after the RS!  

If you think a 30B OS OTC stock is going to run from .0011 to .10 you're smoking something pretty whacky!!  Find a low OS stock with catalysts in place and it's entirely possible but not this one my friend!!!  GLTY
HMBL
manibiotech manibiotech 6 minutos hace
Interesting for sure but not conclusive which he repeat every day 

But there are other things mentioned in that paragraph besides "Neuroscience" ( not Neuro-oncology). And there are other categories of vaccines in development even in neuroscience 


NWBO
FACT-MASTER FACT-MASTER 7 minutos hace
Pivotal Study Design.

Through a meeting with the FDA, the Company obtained feedback on the potential registrational pathway following the Phase 1 ALLOHA trial. Based on this feedback, the Company believes that for a registrational trial: (1) the following proposed patient population i
CDMO
arizona1 arizona1 8 minutos hace
Never trumpers are hilarious and brilliant too.
jimr1717 jimr1717 9 minutos hace
“ which now includes 17 issued U.S. patents and 84 pending”

It has taken them from $90,000 to $2 bucks in share price to get 17 of 101 patents.

There will be people that might need a million dollar share price to brake even by then.

This Fake it sham is
SINT
NoMoDo NoMoDo 10 minutos hace
If we don't see a dime, I will be shocked.
HMBL
Slyhunter Slyhunter 10 minutos hace
I did Uber, when it was worth doing. Made, sometimes $300 a day at the b3e3ginning when they first started in my county, It was disastrous to not get out of the car and inspect the backseat to insure it was clean between fares, especially when driving dr8u8nks home at night. I don't see how Tesla is
TSLA
nfrequent nfrequent 10 minutos hace
Get ready. Phase One complete!!!
https://archive.fast-edgar.com/20241217/AP2Z522CZZ2R52V222JG2WY2CDQEZZ226L62/
RNVA
XMaster2023 XMaster2023 10 minutos hace
Well now kinda sensitive. We can only talk about others tracking the approval one time because it doesn’t meet your short agenda? Funny how an American Society are tracking approval in the UK. They understand the approval will have a big impact on the gene therapy world. Your tacid comments will
NWBO
Guzzi62 Guzzi62 11 minutos hace
I will be holding until approval for sure, but are uncertain on what I will do after.

I want to get out asap, can't stand the management, they are the reason that the pipeline has taken so long due to their own greed.

Furthermore, I really hope for a BO as well.
NWBO
TRAPPER JIM TRAPPER JIM 11 minutos hace
It's a 2006 F150. Really enjoy having hear again. I'm ready to be done with all the work in the new house. Literally been working everyday on it for two months now. Either working before and after work plus working every weekend on it. Haven't had a day off for two months now. Really getting worn ou
Moonboy1 Moonboy1 11 minutos hace
They will pump this when Bitcoin gets down to 103-104 level in my opinion. They will want to steal more money to buy more Bitcoin at these levels. Could go up 5-15% before they rug pull as always. Just watch. Just my opinion.
SHIBUSD
NoMoDo NoMoDo 12 minutos hace
BTW, FORW was once at .0004. I told friends on PM that I believed the stock was going above .25. People that followed me and would discuss stocks daily. I'd say that they all thought I was full of it. Two told me directly. That stock went over a buck along with HMBL. We will see how things go
FORW HMBL
OMOLIVES OMOLIVES 12 minutos hace
Just wrong man. All of it wrong:

https://api.mziq.com/mzfilemanager/v2/d/008ff0e9-ebe5-4a1f-81d8-2566deb10aa1/d106aad0-6693-5a04-bd4f-fdcde3c4cddf?origin=1

https://api.mziq.com/mzfilemanager/v2/d/008ff0e9-ebe5-4a1f-81d8-2566deb10aa1/4303be6b-ea00-b3a1-c292-ab3a338d84fd
HMBL
janice shell janice shell 13 minutos hace
Yes, it was. And fun too.
FACT-MASTER FACT-MASTER 13 minutos hace
TCRX: From the recent 8k filing December 9/24

Solid Tumor Program.

TScan is building and expanding the ImmunoBank of T cell receptors (TCRs) to enable enhanced, multiplex TCR-engineered T cell (TCR-T) therapy, which is designed to address the heterogeneity of solid tumo
TCRX
manibiotech manibiotech 13 minutos hace
Well he is trying very hard to be .... give him credit for trying 
NWBO
TechandBio TechandBio 15 minutos hace
Elon Musk is wowed by Google’s new quantum chip, which it claims ‘cracks a key challenge’ that’s existed for almost 3 decades.
https://fortune.com/2024/12/09/google-willow-quantum-chip-elon-musk/

$GOOGL
GOOGL
TRAPPER JIM TRAPPER JIM 15 minutos hace
Thank you. Had a super nice warm spring like day today. Up in the mid 60s today. 
norisknorewards norisknorewards 15 minutos hace
It specifically calls out neurology, near end of his post.

I found it interesting
NWBO
MoneyMike1 MoneyMike1 15 minutos hace
There was a study recently released by IMCO and AMGN, which triggered many, many articles to be released in the past week or so.

Here's the IMCO page, where you can download the PDF if you wish.

https://imco-org-mx.translate.goog/gas-natural-aliado-de-la-transicion-ene
AMGN
Slyhunter Slyhunter 16 minutos hace
I hope they're right. I can't sell until January for tax purposes, so I'm stuck at the moment. It's almost doubled in value, since I bought the stock. Getting into scary territory, like when I made 600% profit on Kmart stock. I sold too soon, could've made more, but they went bankrupt again a short
TSLA
jimr1717 jimr1717 16 minutos hace
The question is. Who will you appoint for the board monitor position when you leave in a couple of days?
Someone needs to pick up the slack.
HMBL
MrMike241 MrMike241 17 minutos hace
Hope! Finally, something for the shareholders. Now I regret not averaging down at 75 cents 🙃

Keep up the shareholder friendly communications and actions, Charlie! 🤞

$2,000,000 Share Buyback is a good start and it's much appreciated at this critical PPS
NXPL

Su Consulta Reciente

USOTC
CMXC
Cell MedX (PK)
TG
A3TN
AT&T
TG
85G1
StGeorges EcoMining
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados